Search results for "Highlights"
Minority of patients with type 1 diabetes achieve ADA goals for glycemic control, study finds
Despite increasing adoption of insulin pumps and continuous glucose monitors, control of HbA1c hasn't necessarily improved, the authors noted.
https://diabetes.acponline.org/archives/2019/02/08/1.htm
8 Feb 2019
Type 1 diabetes associated with increased atrial fibrillation risk, particularly in women
Risk of atrial fibrillation increased with worse glycemic control and renal complications. Among patients with normoalbuminuria, researchers found no excess risk of atrial fibrillation with an HbA1c less than 9.7% for men or 8.8% for women.
https://diabetes.acponline.org/archives/2017/09/08/2.htm
8 Sep 2017
No increase in mortality with incretin-based drugs compared to other diabetes meds, review finds
The review included 189 randomized controlled trials that compared glucagon-like peptide-1 receptor agonists or dipeptidyl peptidase-2 inhibitors with placebo or other diabetes drugs in patients with type 2 diabetes.
https://diabetes.acponline.org/archives/2017/07/14/3.htm
14 Jul 2017
Behavioral intervention to increase physical activity led to lasting results at 3 years
At three outpatient diabetes clinics in Rome, Italy, participants who received specialized behavioral counseling sessions had greater increases in physical activity and decreases in sedentary time than those who received general physician recommendations.
https://diabetes.acponline.org/archives/2019/03/08/1.htm
8 Mar 2019
Metformin appears to prevent type 2 diabetes, study indicates
Results from the Diabetes Prevention Program Outcomes Study also showed that metformin was cost-effective compared to placebo for patients at high risk of diabetes.
https://diabetes.acponline.org/archives/2017/08/11/2.htm
11 Aug 2017
Second-line therapies for type 2 diabetes may offer similar glycemic control
The only significant difference found by the meta-analysis was a small increase in myocardial infarction and eye disorders with sulfonylureas compared with dipeptidyl peptidase-4 inhibitors.
https://diabetes.acponline.org/archives/2018/09/14/1.htm
14 Sep 2018
Risk score may help predict future glycemic control after new diagnosis of diabetes
The most important predictors of the trajectory of glucose control were body mass index and levels of HbA1c and triglycerides, according to the study of registry data from the Netherlands.
https://diabetes.acponline.org/archives/2017/12/08/3.htm
8 Dec 2017
Diabetes associated with fractures in older male veterans, with comorbidities as mediating factors
The retrospective study involved nearly 2.8 million male veterans 65 to 99 years of age, 32.3% with diabetes, who received primary care at Veterans Health Administration medical centers from 2000 to 2010.
https://diabetes.acponline.org/archives/2017/11/10/2.htm
10 Nov 2017
Dapagliflozin appears effective as adjunct therapy in patients with type 1 diabetes
Patients with type 1 diabetes taking dapagliflozin for 24 weeks had lower HbA1c level, body weight, and insulin dose than those on placebo, according to the industry-funded study.
https://diabetes.acponline.org/archives/2017/10/13/2.htm
13 Oct 2017
Glucose self-monitoring had no effect on glycemic control in non–insulin-treated type 2 diabetes
Although it would seem to make sense that routine glucose self-monitoring provides better outcomes, this long-held belief is not supported by the data, said an editor's note accompanying the study.
https://diabetes.acponline.org/archives/2017/07/14/1.htm
14 Jul 2017